Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.36 |
| ▸ | CA2 | P00918 | 2/20 | 0.36 |
| ▸ | MMP1 | P03956 | 1/20 | 0.30 |
| ▸ | MMP2 | P08253 | 1/20 | 0.30 |
| ▸ | MMP9 | P14780 | 1/20 | 0.30 |
| ▸ | MMP8 | P22894 | 1/20 | 0.30 |
| ▸ | MMP13 | P45452 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29291908 | 0.80 | CA1 (0.33) | CA1CA2 | |
| Lithium SCHEMBL5431630 | 0.77 | CA1 (0.31) | CA1CA2 | |
| SCHEMBL16990129 | 0.74 | CA1 (0.36) | CA1CA2MMP1MMP2MMP9 | |
| SCHEMBL33113 | 0.72 | ALDH1A1 (0.50) | — | |
| SCHEMBL27771794 | 0.72 | ALDH1A1 (0.32) | — | |
| Ammonia Solution, Strong SCHEMBL6836121 | 0.70 | ALDH1A1 (0.48) | — | |
| SCHEMBL17264824 | 0.70 | ALDH1A1 (0.55) | CA1CA2MMP1MMP2MMP9 | |
| SCHEMBL15667764 | 0.68 | — | — | |
| Potassium Ion SCHEMBL8611608 | 0.68 | — | — | |
| SCHEMBL5538924 | 0.68 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8748671-B2 | Ether production method involving alcohol separation by an ionic liquid | IFP Energies Nouvelles (FR) | 2014-06-10 | — | — | US | claimed |
| US-20110021847-A1 | ETHER PRODUCTION METHOD INVOLVING ALCOHOL SEPARATION BY AN IONIC LIQUID | IFP (FR) | 2011-01-27 | — | — | US | claimed |
| US-20050143517-A1 | Compositions consisting of cationic polymers comprising amidinium groups and ionic liquids | CREAVIS GESELLSCHAFT F. TECHN. U. INNOVATION MBH (DE) | 2005-06-30 | — | — | US | claimed |
| EP-1106595-B1 | Improved hydroformylation process with cobalt and/or rhodium based catalysts in a biphasic medium | INST FRANCAIS DU PETROLE (FR) | 2004-08-11 | — | — | EP | claimed |
| US-20120153232-A1 | THERMOPLASTIC MOLDING COMPOSITION | BASF SE (DE) | 2012-06-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110021847-A1 | ETHER PRODUCTION METHOD INVOLVING ALCOHOL SEPARATION BY AN IONIC LIQUID | ADH1C, ADH1A, ADH5 | CA1 3236/4885CA2 4005/4885MMP1 2845/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.